Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Stock Mailbag: NexMed
Biotech Stock Mailbag: NexMed
Biotech Stock Mailbag: NexMed
Submitted by
admin
on February 12, 2010 - 8:19am
Source:
TheStreet.com
News Tags:
NexMed
Sequenom
Vivus
Keryx
Targacept
Immunogen
Cell Therapeutics
Headline:
Biotech Stock Mailbag: NexMed
Do Not Allow Advertisers to Use My Personal information